Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Leukocytes, Collateral Circulation, and Reperfusion in Ischemic Stroke Patients Treated With Mechanical Thrombectomy.

Semerano A, Laredo C, Zhao Y, Rudilosso S, Renú A, Llull L, Amaro S, Obach V, Planas AM, Urra X, Chamorro Á.

Stroke. 2019 Oct 17:STROKEAHA119026743. doi: 10.1161/STROKEAHA.119.026743. [Epub ahead of print]

PMID:
31619153
2.

Validation of a clinical-genetics score to predict hemorrhagic transformations after rtPA.

Carrera C, Cullell N, Torres-Águila N, Muiño E, Bustamante A, Dávalos A, López-Cancio E, Ribó M, Molina CA, Giralt-Steinhauer E, Soriano-Tárraga C, Mola-Caminal M, Jiménez-Conde J, Roquer J, Vives-Bauza C, Navarro RD, Obach V, Arenillas JF, Segura T, Serrano-Heras G, Martí-Fàbregas J, Freijo M, Cabezas JA, Tatlisumak T, Heitsch L, Ibañez L, Cruchaga C, Lee JM, Strbian D, Montaner J, Fernández-Cadenas I; Spanish Stroke Genetic Consortium.

Neurology. 2019 Aug 27;93(9):e851-e863. doi: 10.1212/WNL.0000000000007997. Epub 2019 Jul 31.

PMID:
31366724
3.

Leukoaraiosis May Confound the Interpretation of CT Perfusion in Patients Treated with Mechanical Thrombectomy for Acute Ischemic Stroke.

Rudilosso S, Laredo C, Vivancos C, Urra X, Llull L, Renú A, Obach V, Zhao Y, Moreno JL, Lopez-Rueda A, Amaro S, Chamorro Á.

AJNR Am J Neuroradiol. 2019 Aug;40(8):1323-1329. doi: 10.3174/ajnr.A6139. Epub 2019 Jul 25.

PMID:
31345941
4.

Benefit from mechanical thrombectomy in acute ischemic stroke with fast and slow progression.

Renú Jornet A, Urra X, Laredo C, Montejo C, Rudilosso S, Llull L, Blasco J, Amaro S, Torne R, Obach V, Macho J, Chamorro A.

J Neurointerv Surg. 2019 Jul 4. pii: neurintsurg-2019-015064. doi: 10.1136/neurintsurg-2019-015064. [Epub ahead of print]

PMID:
31273073
5.

The accuracy of ischemic core perfusion thresholds varies according to time to recanalization in stroke patients treated with mechanical thrombectomy: A comprehensive whole-brain computed tomography perfusion study.

Laredo C, Renú A, Tudela R, Lopez-Rueda A, Urra X, Llull L, Macías NG, Rudilosso S, Obach V, Amaro S, Chamorro Á.

J Cereb Blood Flow Metab. 2019 Jun 17:271678X19855885. doi: 10.1177/0271678X19855885. [Epub ahead of print]

PMID:
31208242
6.

Relevance of Collaterals for the Success of Neuroprotective Therapies in Acute Ischemic Stroke: Insights from the Randomized URICO-ICTUS Trial.

Amaro S, Renú A, Laredo C, Castellanos M, Arenillas JF, Llull L, Rudilloso S, Urra X, Obach V, Chamorro Á; on behalf of the URICO-ICTUS investigators.

Cerebrovasc Dis. 2019;47(3-4):171-177. doi: 10.1159/000500712. Epub 2019 Jun 4.

7.

Timing and Relevance of Clinical Improvement After Mechanical Thrombectomy in Patients With Acute Ischemic Stroke.

Rudilosso S, Urra X, Amaro S, Llull L, Renú A, Laredo C, Obach V, Chamorro Á.

Stroke. 2019 Jun;50(6):1467-1472. doi: 10.1161/STROKEAHA.118.024067. Epub 2019 May 22.

PMID:
31113338
8.

Greater infarct growth limiting effect of mechanical thrombectomy in stroke patients with poor collaterals.

Renú A, Laredo C, Montejo C, Zhao Y, Rudilosso S, Macias N, Llull L, Zarco F, Amaro S, Werner M, Obach V, Macho J, Chamorro A, Urra X.

J Neurointerv Surg. 2019 Oct;11(10):989-993. doi: 10.1136/neurintsurg-2018-014668. Epub 2019 Feb 27.

PMID:
30814327
9.

PATJ Low Frequency Variants Are Associated With Worse Ischemic Stroke Functional Outcome.

Mola-Caminal M, Carrera C, Soriano-Tárraga C, Giralt-Steinhauer E, Díaz-Navarro RM, Tur S, Jiménez C, Medina-Dols A, Cullell N, Torres-Aguila NP, Muiño E, Rodríguez-Campello A, Ois A, Cuadrado-Godia E, Vivanco-Hidalgo RM, Hernandez-Guillamon M, Solé M, Delgado P, Bustamante A, García-Berrocoso T, Mendióroz M, Castellanos M, Serena J, Martí-Fàbregas J, Segura T, Serrano-Heras G, Obach V, Ribó M, Molina CA, Alvarez-Sabín J, Palomeras E, Freijo M, Font MA, Rosand J, Rost NS, Gallego-Fabrega C, Lee JM, Heitsch L, Ibanez L, Cruchaga C, Phuah CL, Lemmens R, Thijs V, Lindgren A, Maguire J, Rannikmae K, Sudlow CL, Jern C, Stanne TM, Lorentzen E, Muñoz-Narbona L, Dávalos A, López-Cancio E, Worrall BB, Woo D, Kittner SJ, Mitchell BD, Montaner J, Roquer J, Krupinski J, Estivill X, Rabionet R, Vives-Bauzá C, Fernández-Cadenas I, Jiménez-Conde J.

Circ Res. 2019 Jan 4;124(1):114-120. doi: 10.1161/CIRCRESAHA.118.313533.

PMID:
30582445
10.

Complete reperfusion is required for maximal benefits of mechanical thrombectomy in stroke patients.

Chamorro Á, Blasco J, López A, Amaro S, Román LS, Llull L, Renú A, Rudilosso S, Laredo C, Obach V, Urra X, Planas AM, Leira EC, Macho J.

Sci Rep. 2017 Sep 14;7(1):11636. doi: 10.1038/s41598-017-11946-y.

11.

Complementary examinations other than neuroimaging and neurosonology in acute stroke.

Arboix A, Obach V, Sánchez MJ, Massons J.

World J Clin Cases. 2017 Jun 16;5(6):191-202. doi: 10.12998/wjcc.v5.i6.191. Review.

12.

Uric Acid Therapy Prevents Early Ischemic Stroke Progression: A Tertiary Analysis of the URICO-ICTUS Trial (Efficacy Study of Combined Treatment With Uric Acid and r-tPA in Acute Ischemic Stroke).

Amaro S, Laredo C, Renú A, Llull L, Rudilosso S, Obach V, Urra X, Planas AM, Chamorro Á; URICO-ICTUS Investigators.

Stroke. 2016 Nov;47(11):2874-2876. Epub 2016 Oct 6.

PMID:
27758945
13.

Left Atrial Function Is Impaired in Some Patients With Stroke of Undetermined Etiology: Potential Implications for Evaluation and Therapy.

Sanchis L, Montserrat S, Obach V, Cervera Á, Chamorro Á, Vidal B, Mas-Stachurska A, Bijnens B, Sitges M.

Rev Esp Cardiol (Engl Ed). 2016 Jul;69(7):650-6. doi: 10.1016/j.rec.2015.11.033. Epub 2016 Mar 3. English, Spanish.

PMID:
26949013
14.

Uric Acid Therapy Improves Clinical Outcome in Women With Acute Ischemic Stroke.

Llull L, Laredo C, Renú A, Pérez B, Vila E, Obach V, Urra X, Planas A, Amaro S, Chamorro Á.

Stroke. 2015 Aug;46(8):2162-7. doi: 10.1161/STROKEAHA.115.009960. Epub 2015 Jul 9.

PMID:
26159792
15.

Large APP locus duplication in a sporadic case of cerebral haemorrhage.

Lladó A, Grau-Rivera O, Sánchez-Valle R, Balasa M, Obach V, Amaro S, Rey MJ, Molinuevo JL, Gelpi E, Antonell A.

Neurogenetics. 2014 May;15(2):145-9. doi: 10.1007/s10048-014-0395-z. Epub 2014 Apr 2.

PMID:
24691562
16.

Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy.

Abilleira S, Cardona P, Ribó M, Millán M, Obach V, Roquer J, Cánovas D, Martí-Fàbregas J, Rubio F, Alvarez-Sabín J, Dávalos A, Chamorro A, de Miquel MA, Tomasello A, Castaño C, Macho JM, Ribera A, Gallofré M; Catalan Stroke Code and Reperfusion Consortium.

Stroke. 2014 Apr;45(4):1046-52. doi: 10.1161/STROKEAHA.113.003489. Epub 2014 Mar 4.

PMID:
24595590
17.

Endovascular treatment for M2 occlusions in the era of stentrievers: a descriptive multicenter experience.

Flores A, Tomasello A, Cardona P, de Miquel MA, Gomis M, Garcia Bermejo P, Obach V, Urra X, Martí-Fàbregas J, Cánovas D, Roquer J, Abilleira S, Ribó M; Catalan Stroke Code and Reperfusion Consortium Cat-SCR.

J Neurointerv Surg. 2015 Apr;7(4):234-7. doi: 10.1136/neurintsurg-2014-011100. Epub 2014 Feb 27.

PMID:
24578483
18.

Ultra-early intravenous stroke thrombolysis: do all patients benefit similarly?

Strbian D, Ringleb P, Michel P, Breuer L, Ollikainen J, Murao K, Seiffge DJ, Jung S, Obach V, Weder B, Eskandari A, Gensicke H, Chamorro A, Mattle HP, Engelter S, Leys D, Numminen H, Köhrmann M, Hacke W, Tatlisumak T.

Stroke. 2013 Oct;44(10):2913-6. doi: 10.1161/STROKEAHA.111.000819. Epub 2013 Aug 22.

PMID:
23970791
19.

Risks and benefits of early antithrombotic therapy after thrombolytic treatment in patients with acute stroke.

Amaro S, Llull L, Urra X, Obach V, Cervera Á, Chamorro Á.

PLoS One. 2013 Aug 8;8(8):e71132. doi: 10.1371/journal.pone.0071132. eCollection 2013.

20.

Validation of the DRAGON score in 12 stroke centers in anterior and posterior circulation.

Strbian D, Seiffge DJ, Breuer L, Numminen H, Michel P, Meretoja A, Coote S, Bordet R, Obach V, Weder B, Jung S, Caso V, Curtze S, Ollikainen J, Lyrer PA, Eskandari A, Mattle HP, Chamorro A, Leys D, Bladin C, Davis SM, Köhrmann M, Engelter ST, Tatlisumak T.

Stroke. 2013 Oct;44(10):2718-21. doi: 10.1161/STROKEAHA.113.002033. Epub 2013 Aug 8.

PMID:
23929752
21.

Relationship between onset-to-door time and door-to-thrombolysis time: a pooled analysis of 10 dedicated stroke centers.

Strbian D, Michel P, Ringleb P, Numminen H, Breuer L, Bodenant M, Seiffge DJ, Jung S, Obach V, Weder B, Tiainen M, Eskandari A, Gumbinger C, Gensicke H, Chamorro A, Mattle HP, Engelter ST, Leys D, Köhrmann M, Parkkila AK, Hacke W, Tatlisumak T.

Stroke. 2013 Oct;44(10):2808-13. doi: 10.1161/STROKEAHA.113.000995. Epub 2013 Jul 25.

22.

The Basilar Artery International Cooperation Study (BASICS): study protocol for a randomised controlled trial.

van der Hoeven EJ, Schonewille WJ, Vos JA, Algra A, Audebert HJ, Berge E, Ciccone A, Mazighi M, Michel P, Muir KW, Obach V, Puetz V, Wijman CA, Zini A, Kappelle JL; BASICS Study Group.

Trials. 2013 Jul 8;14:200. doi: 10.1186/1745-6215-14-200.

23.

The outcome of patients with mild stroke improves after treatment with systemic thrombolysis.

Urra X, Ariño H, Llull L, Amaro S, Obach V, Cervera Á, Chamorro Á.

PLoS One. 2013;8(3):e59420. doi: 10.1371/journal.pone.0059420. Epub 2013 Mar 19.

24.

A predictive clinical-genetic model of tissue plasminogen activator response in acute ischemic stroke.

del Río-Espínola A, Fernández-Cadenas I, Giralt D, Quiroga A, Gutiérrez-Agulló M, Quintana M, Fernández-Álvarez P, Domingues-Montanari S, Mendióroz M, Delgado P, Turck N, Ruíz A, Ribó M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Cuadrado-Godia E, Roquer J, Chacón P, Martí-Fábregas J, Sánchez JC; GRECOS Investigators, Montaner J.

Ann Neurol. 2012 Nov;72(5):716-29. doi: 10.1002/ana.23664.

PMID:
23280790
25.

IL1B and VWF variants are associated with fibrinolytic early recanalization in patients with ischemic stroke.

Fernández-Cadenas I, Del Río-Espínola A, Giralt D, Domingues-Montanari S, Quiroga A, Mendióroz M, Ruíz A, Ribó M, Serena J, Obach V, Freijo MM, Martí-Fábregas J, Delgado P, Montaner J.

Stroke. 2012 Oct;43(10):2659-65. Epub 2012 Aug 2.

PMID:
22858724
26.

Role of the MMP9 gene in hemorrhagic transformations after tissue-type plasminogen activator treatment in stroke patients.

Fernández-Cadenas I, Del Río-Espínola A, Carrera C, Domingues-Montanari S, Mendióroz M, Delgado P, Rosell A, Ribó M, Giralt D, Quintana M, Castellanos M, Obach V, Martínez S, Freijo MM, Jiménez-Conde J, Roquer J, Martí-Fábregas J, Molina CA, Alvarez-Sabín J, Montaner J.

Stroke. 2012 May;43(5):1398-400. doi: 10.1161/STROKEAHA.111.639823. Epub 2012 Apr 10.

PMID:
22496335
27.

Single-center experience of cerebral artery thrombectomy using the TREVO device in 60 patients with acute ischemic stroke.

San Román L, Obach V, Blasco J, Macho J, Lopez A, Urra X, Tomasello A, Cervera A, Amaro S, Perandreu J, Branera J, Capurro S, Oleaga L, Chamorro A.

Stroke. 2012 Jun;43(6):1657-9. doi: 10.1161/STROKEAHA.111.640011. Epub 2012 Mar 22.

PMID:
22442176
28.

Multimodal CT-assisted thrombolysis in patients with acute stroke: a cohort study.

Obach V, Oleaga L, Urra X, Macho J, Amaro S, Capurro S, Gomez-Choco M, San Román L, Cervera A, Blasco J, Vargas M, Torres F, Chamorro Á.

Stroke. 2011 Apr;42(4):1129-31. doi: 10.1161/STROKEAHA.110.605766. Epub 2011 Feb 17.

PMID:
21330631
29.

Uric acid levels are relevant in patients with stroke treated with thrombolysis.

Amaro S, Urra X, Gómez-Choco M, Obach V, Cervera A, Vargas M, Torres F, Rios J, Planas AM, Chamorro A.

Stroke. 2011 Jan;42(1 Suppl):S28-32. doi: 10.1161/STROKEAHA.110.596528. Epub 2010 Dec 16.

PMID:
21164140
30.

The I/D polymorphism of the ACE1 gene is not associated with ischaemic stroke in Spanish individuals.

Domingues-Montanari S, Fernandez-Cadenas I, del Rio-Espinola A, Mendioroz M, Ribo M, Obach V, Marti-Fabregas J, Freijo M, Serena J, Corbeto N, Chacon P, Alvarez-Sabin J, Montaner J.

Eur J Neurol. 2010 Nov;17(11):1390-2. doi: 10.1111/j.1468-1331.2010.03022.x.

PMID:
20402757
31.

Association of a genetic variant in the ALOX5AP with higher risk of ischemic stroke: a case-control, meta-analysis and functional study.

Domingues-Montanari S, Fernández-Cadenas I, del Rio-Espinola A, Corbeto N, Krug T, Manso H, Gouveia L, Sobral J, Mendioroz M, Fernández-Morales J, Alvarez-Sabin J, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Ferro JM, Vicente AM, Oliveira SA, Montaner J.

Cerebrovasc Dis. 2010;29(6):528-37. doi: 10.1159/000302738. Epub 2010 Mar 30.

PMID:
20357438
32.

KCNK17 genetic variants in ischemic stroke.

Domingues-Montanari S, Fernández-Cadenas I, Del Río-Espinola A, Mendioroz M, Fernandez-Morales J, Corbeto N, Delgado P, Ribó M, Rubiera M, Obach V, Martí-Fàbregas J, Freijo M, Serena J, Montaner J.

Atherosclerosis. 2010 Jan;208(1):203-9. doi: 10.1016/j.atherosclerosis.2009.07.023. Epub 2009 Jul 31.

PMID:
19647252
33.

Course of matrix metalloproteinase-9 isoforms after the administration of uric acid in patients with acute stroke: a proof-of-concept study.

Amaro S, Obach V, Cervera A, Urra X, Gómez-Choco M, Planas AM, Chamorro A.

J Neurol. 2009 Apr;256(4):651-6. doi: 10.1007/s00415-009-0153-6. Epub 2009 Apr 27.

PMID:
19444535
34.

Monocyte subtypes predict clinical course and prognosis in human stroke.

Urra X, Villamor N, Amaro S, Gómez-Choco M, Obach V, Oleaga L, Planas AM, Chamorro A.

J Cereb Blood Flow Metab. 2009 May;29(5):994-1002. doi: 10.1038/jcbfm.2009.25. Epub 2009 Mar 18.

PMID:
19293821
35.

Stroke induced immunodepression syndrome: from bench to bedside.

Urra X, Obach V, Chamorro A.

Curr Mol Med. 2009 Mar;9(2):195-202. Review.

PMID:
19275627
36.

Monocytes are major players in the prognosis and risk of infection after acute stroke.

Urra X, Cervera A, Obach V, Climent N, Planas AM, Chamorro A.

Stroke. 2009 Apr;40(4):1262-8. doi: 10.1161/STROKEAHA.108.532085. Epub 2009 Jan 22.

PMID:
19164783
37.

Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.

Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL.

Cerebrovasc Dis. 2008;26(2):126-33. doi: 10.1159/000139659. Epub 2008 Jun 17.

PMID:
18560215
38.

Migraine with aura associated with reversible sulcal hyperintensity in FLAIR.

Gómez-Choco M, Capurro S, Obach V.

Neurology. 2008 Jun 10;70(24 Pt 2):2416-8. doi: 10.1212/01.wnl.0000314693.57386.f0. No abstract available.

PMID:
18541878
39.

The response to IV rt-PA in very old stroke patients.

Gómez-Choco M, Obach V, Urra X, Amaro S, Cervera A, Vargas M, Chamorro A.

Eur J Neurol. 2008 Mar;15(3):253-6. doi: 10.1111/j.1468-1331.2007.02042.x. Epub 2008 Jan 9.

PMID:
18190509
40.

Association of specific haplotypes of GAS6 gene with stroke.

Muñoz X, Obach V, Hurtado B, de Frutos PG, Chamorro A, Sala N.

Thromb Haemost. 2007 Aug;98(2):406-12.

PMID:
17721624
41.

Prevention of ischemic stroke: antithrombotic therapy in cardiac embolism.

Cervera A, Amaro S, Obach V, Chamorro A.

Curr Drug Targets. 2007 Jul;8(7):824-31. Review.

PMID:
17630935
42.

The BC genotype of the VNTR polymorphism of platelet glycoprotein Ibalpha is overrepresented in patients with recurrent stroke regardless of aspirin therapy.

Cervera A, Tàssies D, Obach V, Amaro S, Reverter JC, Chamorro A.

Cerebrovasc Dis. 2007;24(2-3):242-6. Epub 2007 Jun 28.

PMID:
17630485
43.

A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.

Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A.

Stroke. 2007 Jul;38(7):2173-5. Epub 2007 May 24.

PMID:
17525395
44.

[Treatment of atrial fibrillation at different levels of health care].

Coll-Vinent B, Junyent M, Orús J, Villarroel C, Casademont J, Miró O, Magriñà J, Obach V, Sánchez M, Sitges M, Bragulat E, Jiménez S, Pacheco G, Brugada J, Mont L.

Med Clin (Barc). 2007 Feb 3;128(4):125-9. Spanish.

PMID:
17288932
45.

Catecholamines, infection, and death in acute ischemic stroke.

Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Gómez-Choco M, Torres F, Planas AM.

J Neurol Sci. 2007 Jan 15;252(1):29-35. Epub 2006 Nov 28.

PMID:
17129587
46.

Frequency and predictors of symptomatic intracerebral hemorrhage in patients with ischemic stroke treated with recombinant tissue plasminogen activator outside clinical trials.

Martí-Fàbregas J, Bravo Y, Cocho D, Martí-Vilalta JL, Díaz-Manera J, San Román L, Puig M, Blanco M, Castellanos M, Millán M, Roquer J, Obach V, Maestre J.

Cerebrovasc Dis. 2007;23(2-3):85-90. Epub 2006 Nov 15.

PMID:
17114877
47.

Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke.

Chamorro A, Amaro S, Vargas M, Obach V, Cervera A, Torres F, Planas AM.

J Neurol Neurosurg Psychiatry. 2006 Nov;77(11):1279-81.

48.

Role of fibrinogen levels and factor XIII V34L polymorphism in thrombolytic therapy in stroke patients.

González-Conejero R, Fernández-Cadenas I, Iniesta JA, Marti-Fabregas J, Obach V, Alvarez-Sabín J, Vicente V, Corral J, Montaner J; Proyecto Ictus Research Group.

Stroke. 2006 Sep;37(9):2288-93. Epub 2006 Jul 20.

PMID:
16857944
49.

Intronic c.573 + 79G>A polymorphism of protein Z gene in haemorrhagic and ischaemic stroke.

Obach V, Muñoz X, Sala N, García de Frutos P, Chamorro A.

Thromb Haemost. 2006 Jun;95(6):1040-1. No abstract available.

PMID:
16732388
50.

Aspirin or anticoagulants in stenosis of the middle cerebral artery: A randomized trial.

Martí-Fàbregas J, Cocho D, Martí-Vilalta JL, Gich I, Belvís R, Bravo Y, Millán M, Castellanos M, Rodríguez-Campello A, Egido J, Geffner D, Gil-Núñez A, Marta J, Navarro R, Obach V, Palomeras E.

Cerebrovasc Dis. 2006;22(2-3):162-9. Epub 2006 May 19.

PMID:
16710082

Supplemental Content

Support Center